4-butyrolactone has been researched along with protolichesterinic acid in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 3 (15.00) | 29.6817 |
2010's | 10 (50.00) | 24.3611 |
2020's | 3 (15.00) | 2.80 |
Authors | Studies |
---|---|
Cai, L; Constant, H; Cordell, GA; Fong, HH; Ingolfsdóttir, K; Kinghorn, AD; Lin, LZ; Pengsuparp, T; Pezzuto, JM; Wagner, H | 1 |
Brynjolfsdottir, A; Gudjonsdottir, GA; Hjalmarsdottir, MA; Ingolfsdottir, K; Sigurdsson, A; Steingrimsson, O | 1 |
Gissurarson, SR; Ingólfsdóttir, K; Ogmundsdóttir, HM; Zoëga, GM | 1 |
Chung, GA; Gissurarson, SR; Ingólfsdóttir, K; Skúlason, VG; Vilhelmsdóttir, M | 1 |
Müller, K | 1 |
Bucar, F; Ingólfsdóttir, K; Ogmundsdóttir, H; Schneider, I | 1 |
Hughes, MA; McFadden, JM; Townsend, CA | 1 |
Caggia, S; Cardile, V; Garbarino, J; Piovano, M; Russo, A | 1 |
Amicosante, G; Bozzi, A; Brisdelli, F; Celenza, G; Garbarino, JA; Nicoletti, M; Perilli, M; Piovano, M; Sellitri, D | 1 |
Authier, H; Boustie, J; Coste, A; Gouault, N; Le Lamer, AC; Pipy, B; Rouaud, I | 1 |
Nicewicz, DA; Riener, M; Zeller, MA | 1 |
El-Naggar, AM; O'Neill, KL; Shrestha, G; St Clair, LL | 1 |
Bessadóttir, M; Eccles, S; Gowan, S; Ogmundsdóttir, HM; Ögmundsdóttir, S; Skúladóttir, EÁ | 1 |
Becker, S; Bessadóttir, M; Eiríksson, FF; Ögmundsdóttir, HM; Ögmundsdóttir, MH; Ómarsdóttir, S; Thorsteinsdóttir, M | 1 |
Lambert, IH; Thorsteinsdottir, M; Thorsteinsdottir, UA | 1 |
Amicosante, G; Bellio, P; Bozzi, A; Brisdelli, F; Celenza, G; Nicoletti, M; Perilli, M; Piovano, M; Sellitri, D | 1 |
Fernandes, RA; Nallasivam, JL | 1 |
Areche, C; Caballero, L; Cartagena, C; Cornejo, A; González, C; Melo, F | 1 |
Cherek, P; Jóhannsson, F; Ögmundsdóttir, HM; Rolfsson, Ó; Xu, M | 1 |
González, EV; Schwaiger, S; Stuppner, H | 1 |
1 review(s) available for 4-butyrolactone and protolichesterinic acid
Article | Year |
---|---|
Pharmaceutically relevant metabolites from lichens.
Topics: 4-Butyrolactone; Anthraquinones; Benzofurans; Depsides; Hydroxybenzoates; Lactones; Lichens; Naphthoquinones | 2001 |
19 other study(ies) available for 4-butyrolactone and protolichesterinic acid
Article | Year |
---|---|
Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase.
Topics: 4-Butyrolactone; Chromatography, High Pressure Liquid; DNA; DNA-Directed RNA Polymerases; Flavonoids; Humans; Kinetics; Nucleic Acid Synthesis Inhibitors; Plants, Medicinal; Reverse Transcriptase Inhibitors; Serum Albumin, Bovine; Templates, Genetic; Triterpenes; Xanthenes; Xanthones; Zidovudine | 1995 |
In vitro susceptibility of Helicobacter pylori to protolichesterinic acid from the lichen Cetraria islandica.
Topics: 4-Butyrolactone; Helicobacter pylori; Lichens; Microbial Sensitivity Tests; Plant Extracts | 1997 |
Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes.
Topics: 4-Butyrolactone; Depsides; Ethanol; Fibroblasts; Humans; Lactones; Lichens; Lipoxygenase Inhibitors; Lymphocyte Activation; Lymphocytes; Salicylates; Tumor Cells, Cultured | 1998 |
Antimycobacterial activity of lichen metabolites in vitro.
Topics: 4-Butyrolactone; Anti-Bacterial Agents; Benzofurans; Depsides; Hydroxybenzoates; Lactones; Lichens; Microbial Sensitivity Tests; Mycobacterium; Salicylates | 1998 |
Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 4-Butyrolactone; Benzoates; Benzofurans; Blood Platelets; Depsides; Emodin; Humans; In Vitro Techniques; Lactones; Lichens; Lipoxygenase; Lipoxygenase Inhibitors; Molecular Structure; Resorcinols; Salicylates | 2004 |
New alpha-methylene-gamma-butyrolactones with antimycobacterial properties.
Topics: 4-Butyrolactone; Anti-Bacterial Agents; Microbial Sensitivity Tests; Mycobacterium bovis; Structure-Activity Relationship | 2005 |
Effect of vicanicin and protolichesterinic acid on human prostate cancer cells: role of Hsp70 protein.
Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Comet Assay; Depsides; DNA Fragmentation; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Hydroxybenzoates; L-Lactate Dehydrogenase; Lactones; Male; Prostatic Neoplasms; Reactive Oxygen Species | 2012 |
Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study.
Topics: 4-Butyrolactone; Anisoles; Antioxidants; Apoptosis; Benzofurans; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Depsides; Free Radical Scavengers; Humans; Hydroxybenzoates; Lactones; Lichens; Oxidative Stress; Reactive Oxygen Species; Salicylates | 2013 |
Protolichesterinic acid derivatives: α-methylene-γ-lactones as potent dual activators of PPARγ and Nrf2 transcriptional factors.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lactones; Macrophages; Mice; Molecular Structure; NF-E2-Related Factor 2; PPAR gamma; Structure-Activity Relationship | 2014 |
Butyrolactone synthesis via polar radical crossover cycloaddition reactions: diastereoselective syntheses of methylenolactocin and protolichesterinic acid.
Topics: 4-Butyrolactone; Alkenes; Catalysis; Cyclization; Cycloaddition Reaction; Lactones; Molecular Structure; Oxidation-Reduction; Stereoisomerism | 2014 |
Anticancer activities of selected species of North American lichen extracts.
Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Benzofurans; Cell Line, Tumor; Cell Survival; Humans; Inhibitory Concentration 50; Lactones; Lichens; Lymphocytes; Molecular Structure; Salicylates; Thymidine Kinase; Tumor Suppressor Protein p53; United States | 2015 |
Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells.
Topics: 4-Butyrolactone; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Fatty Acid Synthases; Female; Humans; Lapatinib; Lichens; Molecular Structure; Quinazolines; Receptor, ErbB-2; Signal Transduction | 2014 |
Anti-proliferative and pro-apoptotic effects of lichen-derived compound protolichesterinic acid are not mediated by its lipoxygenase-inhibitory activity.
Topics: 4-Butyrolactone; Apoptosis; Arachidonate 12-Lipoxygenase; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cell Proliferation; Cytoplasm; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lichens; Multiple Myeloma; Pancreatic Neoplasms | 2015 |
Protolichesterinic Acid, Isolated from the Lichen Cetraria islandica, Reduces LRRC8A Expression and Volume-Sensitive Release of Organic Osmolytes in Human Lung Epithelial Cancer Cells.
Topics: 4-Butyrolactone; Apoptosis; Arachidonate 5-Lipoxygenase; bcl-2-Associated X Protein; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Humans; Hydroxyeicosatetraenoic Acids; Lichens; Lung Neoplasms; Membrane Proteins; Parmeliaceae; Taurine | 2016 |
Protolichesterinic acid enhances doxorubicin-induced apoptosis in HeLa cells in vitro.
Topics: 4-Butyrolactone; Antibiotics, Antineoplastic; Apoptosis; Doxorubicin; Drug Synergism; HeLa Cells; Humans; Molecular Docking Simulation | 2016 |
A protecting-group-free synthesis of (+)-nephrosteranic, (+)-protolichesterinic, (+)-nephrosterinic, (+)-phaseolinic, (+)-rocellaric acids and (+)-methylenolactocin.
Topics: 4-Butyrolactone; Furans; Lactones; Molecular Conformation; Stereoisomerism | 2017 |
The Fumarprotocetraric Acid Inhibits Tau Covalently, Avoiding Cytotoxicity of Aggregates in Cells.
Topics: 4-Butyrolactone; Antarctic Regions; Ascomycota; Cell Line, Tumor; Fumarates; Humans; Lichens; Neurodegenerative Diseases; Parmeliaceae; Protein Aggregates; tau Proteins; Tauopathies | 2021 |
The Anti-Proliferative Lichen-Compound Protolichesterinic Acid Inhibits Oxidative Phosphorylation and Is Processed via the Mercapturic Pathway in Cancer Cells.
Topics: 4-Butyrolactone; Cell Proliferation; Glutathione; Lichens; Neoplasms; Oxidation-Reduction; Oxidative Phosphorylation; Reactive Oxygen Species | 2022 |
Two-step isolation of the two major paraconic acids of Cetraria islandica.
Topics: 4-Butyrolactone; Chromatography, Liquid; Lichens; Parmeliaceae | 2023 |